Lisanti Capital Growth’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-81,398	Closed	-$3.94M	–	111
2020 Q2	$3.94M	Sell	81,398 -6,868	-8%	-$330K	0.8%	64
2020 Q1	$3.73M	Sell	88,266 -34,285	-28%	-$1.41M	1.23%	28
2019 Q4	$5.24M	Buy	122,551 +15,026	+14%	+$654K	1.39%	27
2019 Q3	$3.87M	Buy	107,525 +65,665	+157%	+$1.99M	1.26%	31
2019 Q2	$1.12M	Sell	41,860 -64,675	-61%	-$1.65M	0.36%	81
2019 Q1	$2.86M	Buy	+106,535	New	+$2.49M	1.01%	39
2016 Q3	–	Sell	-12,355	Closed	-$401K	–	95
2016 Q2	$401K	Sell	12,355 -25,215	-67%	-$844K	0.6%	75
2016 Q1	$1.05M	Buy	37,570 +23,277	+163%	+$508K	1.24%	32
2015 Q4	$510K	Sell	14,293 -4,892	-25%	-$172K	0.54%	75
2015 Q3	$634K	Sell	19,185 -25,291	-57%	-$1.05M	0.57%	72
2015 Q2	$1.86M	Sell	44,476 -16,642	-27%	-$644K	1.34%	35
2015 Q1	$1.99M	Sell	61,118 -68,673	-53%	-$2.36M	1.14%	39
2014 Q4	$4.12M	Buy	129,791 +26,241	+25%	+$744K	2.06%	4
2014 Q3	$2.56M	Buy	+103,550	New	+$2.42M	1.29%	32
2014 Q1	–	Sell	-38,760	Closed	-$969K	–	95
2013 Q4	$969K	Sell	38,760 -27,595	-42%	-$651K	0.41%	88
2013 Q3	$1.82M	Buy	+66,355	New	+$1.39M	0.83%	54